TPD52L1
Tumor protein D53
Also known as: D53, hD53, TPD53, TPD53_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16890
- Gene
- TPD52L1
- Ensembl
- ENSG00000111907
- Chromosome
- 6
- Canonical length
- 204 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cell Junctions,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of a family of proteins that contain coiled-coil domains and may form hetero- or homomers. The encoded protein is involved in cell proliferation and calcium signaling. It also interacts with the mitogen-activated protein kinase kinase kinase 5 (MAP3K5/ASK1) and positively regulates MAP3K5-induced apoptosis. Multiple alternatively spliced transcript variants have been observed. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
204 residues, UniProt reviewed canonical sequence.
>Q16890|TPD52L1
1 MEAQAQGLLE TEPLQGTDED AVASADFSSM LSEEEKEELK AELVQLEDEI TTLRQVLSAK
61 ERHLVEIKQK LGMNLMNELK QNFSKSWHDM QTTTAYKKTH ETLSHAGQKA TAAFSNVGTA
121 ISKKFGDMSY SIRHSISMPA MRNSPTFKSF EERVETTVTS LKTKVGGTNP NGGSFEEVLS
181 STAHASAQSL AGGSRRTKEE ELQCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TPD52L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 281 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 281 nTPM
- adrenal gland: 249 nTPM
- choroid plexus: 212 nTPM
- basal ganglia: 165 nTPM
- esophagus: 144 nTPM
- tongue: 118 nTPM
Single-cell type
- esophageal apical cells: 1,258 nCPM
- esophageal suprabasal cells: 883 nCPM
- myonuclei: 858 nCPM
- choroid plexus epithelial cells: 741 nCPM
- salivary acinar cells: 695 nCPM
- adrenal cortex cells: 645 nCPM
Immune cell
- neutrophil: 2.7 nTPM
- NK-cell: 2.6 nTPM
- basophil: 1.5 nTPM
- naive CD4 T-cell: 0.7 nTPM
- memory CD4 T-cell: 0.6 nTPM
- naive CD8 T-cell: 0.5 nTPM
Brain region
- choroid plexus: 86 nTPM
- basal ganglia: 71 nTPM
- amygdala: 44 nTPM
- hypothalamus: 41 nTPM
- medulla oblongata: 40 nTPM
- cerebral cortex: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.11
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G2/M transition of mitotic cell cycle
- positive regulation of apoptotic signaling pathway
- positive regulation of JNK cascade
- positive regulation of MAP kinase activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TPD52L1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TPD52L1 as an antibody target. Whether an autoantibody or antibody against TPD52L1 could matter depends on whether native TPD52L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TPD52L1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TPD52L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...